Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 2,140.30
+26.90 (1.27%)
Jun 13, 2025, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 162.70 billion as of June 13, 2025. Its market cap has increased by 65.49% in one year.
Market Cap
162.70B
Enterprise Value
154.82B
Revenue
19.37B
Ranking
n/a
PE Ratio
30.34
Stock Price
2,140.30
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 162.70B, an increase of 2,905,694.50%. That is a compound annual growth rate of 55.41%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,049.60B |
| Divi's Laboratories | 1,769.88B |
| Cipla | 1,215.74B |
| Apollo Hospitals Enterprise | 1,005.70B |
| Mankind Pharma | 982.83B |
| Zydus Lifesciences | 981.03B |
| Aurobindo Pharma | 668.04B |
| Alkem Laboratories | 579.59B |